Search Results 271-280 of 17149 for nivolumab
This is a standard of care (SOC) study. A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative ...
Waqas A, Zaffar J, Jalil A, Butt S. Nivolumab-Induced Isolated Neutropenia. Cureus. 2023 Sep; 15 (9):e45675 Epub 2023 Sept 21. View PubMed; Butt S, Kiran S ...
The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with nivolumab in adult subjects with advanced and/or ...
This study hopes to determine the levels of bladder cancer-derived extracellular vesicles pre- and post-RC. In-home Versus In-Clinic Subcutaneous Nivolumab ...
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 ...
... nivolumab administered alone or in combination with ipilimumab in patients with different lines of GBM therapy. SPORT-DMG Rochester, MN; Scottsdale/Phoenix ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!